| Chen, Feng |
| Recruiting | 3 | 1184 | RoW | Aspirin, Placebo, Best medical management | Capital Medical University | Acute Ischemic Stroke, Cerebral Infarction | 03/26 | 03/26 | | |
| Active, not recruiting | 1/2 | 196 | RoW | CAR T-cell therapy | The First Affiliated Hospital of Soochow University, Shanghai Unicar-Therapy Bio-medicine Technology Co.,Ltd, The Second People's Hospital of Huai'an, Third Military Medical University | Acute Lymphoblastic Leukemia with Failed Remission | 08/24 | 12/25 | | |
NCT06340646: Washington University Participant Engagement and Cancer Genomic Sequencing Center (WU-PE-CGS) |
|
|
| Recruiting | N/A | 990 | US | Return of Genetic Results: Biomarker information from cancer cells, Return of Genetic Results: Inherited mutations related to cancer, Return of Genetic Results: Inherited mutations related to other medical issues | Washington University School of Medicine, National Cancer Institute (NCI), The Foundation for Barnes-Jewish Hospital | Cholangiocarcinoma, Multiple Myeloma, Colon Cancer, Rectal Cancer | 01/27 | 01/27 | | |
NCT04728568: Exploratory Study of PD-1 Neoadjuvant Treatment of Recurrent Meningioma |
|
|
| Recruiting | N/A | 15 | RoW | Sintilimab, Sintilimab Injection | Beijing Tiantan Hospital | Meningioma, Malignant | 06/23 | 06/25 | | |
NCT05202626: Detection and Biopsy Guidance of Nasopharyngeal Carcinoma Based on Artificial Intelligence and Endoscopic Images |
|
|
| Recruiting | N/A | 100 | RoW | Nasopharyngeal Endoscopy image-guided Biopsy | Chinese Academy of Sciences, Sun Yat-sen University, Guangdong Provincial People's Hospital, Nanfang Hospital, Southern Medical University, Fujian Cancer Hospital, Hainan People's Hospital | Nasopharyngeal Carcinoma, Image-Guided Biopsy | 10/23 | 06/25 | | |
| Recruiting | N/A | 60 | RoW | CMV/EBV-CMI | The First Affiliated Hospital of Soochow University | Hematopoietic Stem Cell Transplantation, Cytomegalovirus Infections, Epstein-Barr Virus Infections | 07/25 | 07/26 | | |
| Liu, Ying Su |
NCT04468529: Evaluate the Effect of Injectable Neucardin on the Cardiac Function of Subjects With Chronic Systolic Heart Failure |
|
|
| Completed | 3 | 154 | RoW | Recombinant human Neuregulin for injection, Neucardin, Placebo | Zensun Sci. & Tech. Co., Ltd. | Chronic Systolic Heart Failure | 04/22 | 04/24 | | |
NCT05745259: Thrombolysis Treated With TNK-tPA in Acute Ischemic Stroke Patients （3T Stroke-Ⅲ） |
|
|
| Recruiting | 3 | 1630 | RoW | Alteplase, rt-PA, Tenecteplase, TNK-tPA | Beijing Tiantan Hospital, Jiangsu FENG HUA Biotech Pharmaceutical Co., Ltd, The Place Pharmaceutical(Jiangsu) Co., Ltd | Acute Ischemic Stroke | 11/23 | 03/24 | | |
| Recruiting | 3 | 918 | Europe, Canada, Japan, RoW | Zanidatamab, ZW25, JZP598, Tislelizumab, Trastuzumab, Herceptin®, Capecitabine, Oxaliplatin, Cisplatin, 5-Fluorouracil | Jazz Pharmaceuticals, BeiGene, Ltd. | Gastric Neoplasms, Gastroesophageal Adenocarcinoma, Esophageal Adenocarcinoma | 05/25 | 05/26 | | |
PANOVA-3, NCT03377491: Effect of Tumor Treating Fields (TTFields, 150 kHz) as Front-Line Treatment of Locally-advanced Pancreatic Adenocarcinoma Concomitant With Gemcitabine and Nab-paclitaxel |
|
|
| Completed | 3 | 571 | Europe, Canada, US, RoW | NovoTTF-200T, TTFields, Gemcitabine, nab paclitaxel | NovoCure Ltd. | Pancreas Adenocarcinoma | 10/24 | 10/24 | | |
JSKN003-302, NCT06079983: JSKN003 Versus Treatment Of Physician'S Choice For HER2-low, Unresectable and/or Metastatic Breast Cancer Subjects |
|
|
| Not yet recruiting | 3 | 400 | RoW | JSKN003, Capecitabine tablets, Gemcitabine hydrochloride for injection, Vinorelbine tartrate injection, Paclitaxel for injection (albumin-bound type), Docetaxel injection, Eribulin mesylate injection | Jiangsu Alphamab Biopharmaceuticals Co., Ltd | Breast Cancer | 04/25 | 03/29 | | |
STRIDES, NCT05490563: - a Clinical Research Study of an Investigational New Drug to Treat Spinocerebellar Ataxia |
|
|
| Terminated | 2/3 | 23 | Europe, US, RoW | SLS-005, Placebo | Seelos Therapeutics, Inc. | Spinocerebellar Ataxia Type 3 | 11/23 | 11/23 | | |
HNGC-004, NCT03939962: Camrelizumab Combined With FOLFOX Neoadjuvant Therapy for Resectable Gastric and Gastroesophageal Junctional Adenocarcinoma |
|
|
| Active, not recruiting | 2 | 60 | RoW | SHR1210 combined with FOLFOX | Henan Cancer Hospital | Gastric Cancer | 05/21 | 05/24 | | |
| Recruiting | 2 | 20 | RoW | camrelizumab, SHR-1210, Apatinib Mesylate | Henan Cancer Hospital | Advanced Gastric Carcinoma | 06/22 | 08/23 | | |
MRG002-002, NCT04837508: A Study of MRG002 in the Treatment of HER2-positive Unresectable, Locally Advanced or Metastatic Biliary Tract Cancer |
|
|
| Recruiting | 2 | 86 | RoW | MRG002 | Shanghai Miracogen Inc. | Advanced or Metastatic Biliary Tract Cancer | 12/22 | 08/23 | | |
NCT05188209: A Study to Evaluate the Efficacy and Safety of MRG003 in Patients With Advanced Gastric Cancer. |
|
|
| Recruiting | 2 | 60 | RoW | MRG003 | Shanghai Miracogen Inc. | Advanced or Metastatic Gastric Cancer, Advanced or Metastatic Gastroesophageal Junction Carcinoma | 03/23 | 08/23 | | |
| Not yet recruiting | 2 | 22 | RoW | Cadonilimab (®), a PD-1/CTLA-4 bi-specific antibody, Neoadjuvant therapy with Cadonilimab | LiuYing | Colorectal Cancer, Mismatch Repair-deficient (dMMR), Microsatellite Instability-high (MSI-H), Neoadjuvant Therapy | 12/23 | 12/23 | | |
NCT05247216: A Phase 2 Study of Hemay007 in Patients With Rheumatoid Arthritis |
|
|
| Completed | 2 | 140 | RoW | Hemay007 800 mg QD group, Hemay007 1200 mg QD group, Hemay007 600 mg QD group, Hemay007 placebo group | Tianjin Hemay Pharmaceutical Co., Ltd | Rheumatoid Arthritis | 06/23 | 06/23 | | |
NCT06173037: RC88 in Platinum-Resistant Recurrent Epithelial Ovarian Cancer, Fallopian Tube Cancer, and Primary Peritoneal Cancer |
|
|
| Recruiting | 2 | 88 | RoW | RC88, RC88 for Injection | RemeGen Co., Ltd. | Primary Peritoneal Cancer, Fallopian Tube Cancer, Epithelial Ovarian Cancer | 06/26 | 12/26 | | |
NCT06231680: Thalidomide Prevention or Treatment of Camrelizumab-induced Reactive Cutaneous Capillary Endothelial Proliferation (RCCEP) |
|
|
| Recruiting | 2 | 132 | RoW | Camrelizumab, SHR-1210, Thalidomide 50mg, Thalidomide, Thalidomide 100mg, Thalidomide 200mg, Chemotherapy, Platinum-based chemotherapy | Henan Cancer Hospital, First Affiliated Hospital Xi'an Jiaotong University | Lung Cancer, Nonsmall Cell, Esophageal Carcinoma | 06/24 | 09/25 | | |
NCT06227325: Disitamab Vedotin Combined With Sintilimab and XELOX Perioperative Treatment for Resectable Gastric Caner With HER2 Overexpression |
|
|
| Not yet recruiting | 2 | 27 | RoW | RC48 combined with Sintilimab and XELOX, Disitamab vedotin combined with Sintilimab and XELOX | Henan Cancer Hospital | Gastric Cancer | 12/24 | 12/25 | | |
NCT06293014: TAS-102 Combined With Bevacizumab for Second-line Maintenance Treatment of Advanced Colorectal Cancer |
|
|
| Recruiting | 2 | 224 | RoW | TAS-102+bevacizumab, Trifluridine and Tipiracil Hydrochloride Tablets; bevacizumab, Standard chemotherapy+bevacizumab, Bevacizumab | Henan Cancer Hospital | Colorectal Cancer | 10/25 | 11/26 | | |
NCT06749730: Adebrelimab Combined with Apatinib and Gemcitabine and Cisplatin (GP) First-line Treatment for Unresectable Biliary Tract Carcinoma |
|
|
| Recruiting | 2 | 63 | RoW | Adebrelimab, Apatinib, gemcitabine and cisplatin | Henan Cancer Hospital | Unresectable Biliary Tract Carcinoma | 12/26 | 06/27 | | |
NCT04774419: Radiation and TSR-042 (Dostarlimab) in People With Endometrial Cancer After They Receive Surgery |
|
|
| Recruiting | 2 | 62 | US | Intensity modulated radiation therapy (IMRT), Dostarlimab, TSR-042, Hypofractionated IMRT | Memorial Sloan Kettering Cancer Center, Tesaro, Inc. | Endometrial Cancer | 02/26 | 02/26 | | |
ACTIVATE, NCT05819359: Efficacy, Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of BIA 28-6156 in GBA-PD |
|
|
| Active, not recruiting | 2 | 237 | Europe, Canada, US | BIA 28-6156 10 mg, BIA 28-6156 60 mg, Placebo | Bial R&D Investments, S.A. | Parkinson's Disease | 03/26 | 07/26 | | |
NCT06166836: a Study to Evaluate the Safety and Efficacy of D-1553 Combined With IN10018 in KRAS G12C Mutant Solid Tumors |
|
|
| Recruiting | 1/2 | 140 | RoW | D1553, IN10018（Ifebemtinib）, BI 853520 | InxMed (Shanghai) Co., Ltd., InventisBio Co., Ltd | Solid Tumor | 12/25 | 12/26 | | |
NCT04755543: A Study of LP002 for the Treatment of Patients With Malignant Digestive System Neoplasms |
|
|
| Recruiting | 1 | 94 | RoW | LP002, Cisplatin, Fluorouracil, OH2 oncolytic virus | Taizhou HoudeAoke Biomedical Co., Ltd. | Digestive System Neoplasms | 06/21 | 06/22 | | |
| Enrolling by invitation | N/A | 200 | RoW | the paste group, the meridian group | The Affiliated Hospital of Qingdao University | Massage, Meridian, Pain | 05/21 | 05/21 | | |
| Recruiting | N/A | 10000 | RoW | Coronary angiography, CT angiography of aorta, CTA, CT angiography of pulmonary arteries., Electrocardiogram, ECG, Cardiac Troponin, Biomarkers of myocardial injury | West China Hospital | Chest Pain, Acute Aortic Dissection, Pulmonary Embolism, Acute Myocardial Infarction Type 1, Acute Coronary Syndrome | 10/21 | 10/22 | | |
NCT06087380: Auricular Acupressure on Improving Pain and Heart Variability in Patients After Cervical Spine Surgery |
|
|
| Completed | N/A | 62 | RoW | auricular acupressure, standard ward care | National Taipei University of Nursing and Health Sciences, Taipei Veterans General Hospital, Taiwan | Auricular Acupressure, Cervical Spine Surgery | 03/23 | 03/23 | | |
NCT05528484: Self-reported Outcomes of Patients in ERAS Nursing |
|
|
| Recruiting | N/A | 600 | RoW | ERAS nursing, non eras nursing | The Second Hospital of Shandong University | Enhanced Recovery After Surgery | 06/23 | 08/27 | | |
NCT05455099: A Multicenter Study of Ultrafast Pulse Wave Velocity in Obese Chinese Han Adults |
|
|
| Recruiting | N/A | 2400 | RoW | Carotid ultrasound examination 1, Carotid ultrasound examination 2 | First Hospital of China Medical University | Carotid Artery Diseases | 08/23 | 07/24 | | |
| Recruiting | N/A | 70 | US | | Koneksa Health, Merck Sharp & Dohme LLC, Regeneron Pharmaceuticals | Parkinson Disease | 08/25 | 09/25 | | |
MET-LVH, NCT05719337: Multi-Modality Echocardiographic Techniques in Pathological Left Ventricular Hypertrophy Adults |
|
|
| Recruiting | N/A | 660 | RoW | Echocardiography | First Hospital of China Medical University, Wuhan Union Hospital, China | Left Ventricular Hypertrophy | 08/24 | 08/25 | | |
| Xiaodong, Wang |
| Recruiting | 3 | 440 | RoW | PFO closure device, Aspirin and clopidogrel, Triptans | Guangdong Provincial People's Hospital | PFO - Patent Foramen Ovale, Migraine | 07/24 | 07/25 | | |
| Tian, Jing |
NCT05688696: Evaluate the Efficacy and Safety of Orelabrutinib in Adult Patients With Systemic Lupus Erythematosus |
|
|
| Recruiting | 2 | 186 | RoW | Orelabrutinib (Low Dose), Orelabrutinib (High Dose), Orelabrutinib Placebo | Beijing InnoCare Pharma Tech Co., Ltd. | Systemic Lupus Erythematosus, SLE | 08/25 | 05/26 | | |
NCT06010901: A Clinical Study of TQB2618 Injection Monotherapy and Combination Regimen (With Penpulimab Injection ±Anlotinib Hydrochloride Capsules) in the Four or Later Lines of Treatment of Advanced Colorectal Cancer. |
|
|
| Recruiting | 1 | 75 | RoW | TQB2618 injection, Penpulimab injection, Anlotinib hydrochloride capsules | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Colorectal Cancer | 03/25 | 07/25 | | |
IPAKA, NCT03763448: Infrapatellar Fat Pad Preservation Versus Resection on Clinical Outcomes After Total Knee Arthroplasty |
|
|
| Recruiting | N/A | 360 | RoW | Infrapatellar Fat Pad preservation, Infrapatellar fat pad retention, Infrapatellar Fat Pad resection | Zhujiang Hospital, Peking Union Medical College Hospital, Peking University People's Hospital, Xiangya Hospital of Central South University, The First Affiliated Hospital of Anhui Medical University, First Affiliated Hospital of Jinan University, Anhui Provincial Hospital, Tianjin Hospital, Affiliated Hospital of Youjiang Medical University for Nationalities | Knee Osteoarthritis, Arthropathy of Knee | 12/22 | 12/23 | | |
| Xiang, Yin |
NCT05638269: A Multicentre Study on Features of the Gut Microbiota of Patients With Critical Chronic Diseases in China |
|
|
| Recruiting | N/A | 12000 | RoW | no intervention | Zhujiang Hospital, National Natural Science Foundation of China | Essential Hypertension, Liver Cancer, Nasopharyngeal Cancer, Pancreatic Cancer, Lung Cancer, Chronic Kidney Diseases, Acute Coronary Syndrome, Epilepsy, Gastric Cancer, Primary Aldosteronism, Subclinical hypothyroïdism | 12/24 | 12/25 | | |
| Huang, Huiying |
| Recruiting | 3 | 1184 | RoW | Aspirin, Placebo, Best medical management | Capital Medical University | Acute Ischemic Stroke, Cerebral Infarction | 03/26 | 03/26 | | |
